March 14, 2013

Mylan has settled a patent-infringement lawsuit filed by Shionogi over its generic version of a drug for diabetes, Mylan said.

February 26, 2013

The Food and Drug Administration has approved a drug for postmenopausal women who experience pain during sex.

October 10, 2012

Mylan has settled a patent infringement suit over a drug used to treat respiratory diseases, Mylan said.

August 28, 2012

Merz announced it has acquired a medication designed to treat a condition associated with such neurologic conditions as cerebral palsy.

June 29, 2012

The Food and Drug Administration has accepted a regulatory approval application for a drug made by Shionogi for treating vulvar and vaginal atrophy due to menopause.

April 23, 2012

Watson Pharmaceuticals announced the launch of an authorized generic version of a drug used to lower blood glucose in patients with Type 2 diabetes.

April 10, 2012

Prasco Labs has launched an authorized generic version of a blood-pressure drug made by Shionogi, the company said.

September 12, 2011

The Generic Pharmaceutical Association has named Ralph Neas as its new president and CEO.

August 22, 2011

Prasco will market an authorized generic drug for urinary tract infections under an agreement with Shionogi, the company said Monday.

July 25, 2011

Prasco Labs has contracted to sell an authorized generic version of a painkiller made by Shionogi, Prasco said Monday.

May 23, 2011

A generic drug maker has been granted approval from the Food and Drug Administration to manufacture its version of a urinary tract infection treatment.

April 7, 2011

A treatment made by Shionogi for chronic, severe drooling in children and teenagers with neurological conditions has become available, the drug maker said Thursday.

January 10, 2011

Drug maker Shionogi has launched a new medication for attention deficit hyperactivity disorder, the company said Monday.

October 3, 2010

The Food and Drug Administration has approved a nonstimulant drug for treating attention deficit hyperactivity...